Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.
Sotgiu G, Tiberi S, D'Ambrosio L, Centis R, Alffenaar JW, Caminero JA, Abdo Arbex M, Alarcon Guizado V, Aleksa A, Dore S, Gaga M, Gualano G, Kunst H, Payen MC, Roby Arias AJ, Skrahina A, Solovic I, Sulis G, Tadolini M, Zumla A, Migliori GB; International Carbapenem Study Group. Sotgiu G, et al. Among authors: migliori gb. Eur Respir J. 2016 Nov;48(5):1503-1507. doi: 10.1183/13993003.01249-2016. Epub 2016 Sep 1. Eur Respir J. 2016. PMID: 27587544 Free article. No abstract available.
Mycobacterium tuberculosis complex drug resistance in Italy.
Migliori GB, Centis R, Fattorini L, Besozzi G, Saltini C, Scarparo C, Cirillo D, Gori A, Cassone A, Piersimoni C. Migliori GB, et al. Emerg Infect Dis. 2004 Apr;10(4):752-3. doi: 10.3201/eid1004.030667. Emerg Infect Dis. 2004. PMID: 15211998 Free PMC article. No abstract available.
Multidrug- and extensively drug-resistant tuberculosis, Germany.
Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group. Eker B, et al. Among authors: migliori gb. Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729. Emerg Infect Dis. 2008. PMID: 18976552 Free PMC article.
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment.
Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Guenther G, Hoffmann H, Cirillo DM, Toungossova O, Kliiman K, De Lorenzo S, Spanevello A, Lange C; Tuberculosis Network European Trialsgroup. Migliori GB, et al. Clin Infect Dis. 2009 Jul 15;49(2):315-6; author reply 317. doi: 10.1086/600060. Clin Infect Dis. 2009. PMID: 19538069 No abstract available.
Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study.
Jafari C, Thijsen S, Sotgiu G, Goletti D, Domínguez Benítez JA, Losi M, Eberhardt R, Kirsten D, Kalsdorf B, Bossink A, Latorre I, Migliori GB, Strassburg A, Winteroll S, Greinert U, Richeldi L, Ernst M, Lange C; Tuberculosis Network European Trialsgroup. Jafari C, et al. Among authors: migliori gb. Am J Respir Crit Care Med. 2009 Oct 1;180(7):666-73. doi: 10.1164/rccm.200904-0557OC. Epub 2009 Jul 9. Am J Respir Crit Care Med. 2009. PMID: 19590020 Free PMC article. Clinical Trial.
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
Sotgiu G, Lange C, Richardson MD, Matteelli A, Centis R, Eker B, Guenther G, Spanevello A, Migliori GB; TBNET. Sotgiu G, et al. Among authors: migliori gb. J Antimicrob Chemother. 2009 Oct;64(4):879-83; author reply 883-4. doi: 10.1093/jac/dkp265. Epub 2009 Aug 3. J Antimicrob Chemother. 2009. PMID: 19651787 No abstract available.
595 results